SCHEMBL17720385

SCHEMBL17720385

c1ccc(N(c2ccc(-c3ccc(-c4cc(-c5ccc6c7ccccc7n(-c7ccccc7)c6c5)cc(-c5ccc6c7ccccc7n(-c7ccccc7)c6c5)c4)cc3)cc2)c2cccc3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34
▸ HDAC4 P56524 1/20 0.32
▸ SIGMAR1 Q99720 3/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ BRCA1 P38398 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ F2 P00734 1/20 0.31
▸ F10 P00742 1/20 0.31
▸ PRSS1 P07477 1/20 0.31
▸ TSPO P30536 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17720382 1.00 KDM4E (0.42) KDM4EATML3MBTL1RXRARXRB
SCHEMBL17250132 0.98 L3MBTL1 (0.42) KDM4EATML3MBTL1RXRARXRB
SCHEMBL19383181 0.98 L3MBTL1 (0.44) KDM4EATML3MBTL1RXRARXRB
SCHEMBL19383063 0.98 L3MBTL1 (0.44) KDM4EATML3MBTL1RXRARXRB
SCHEMBL16985962 0.97 KDM4E (0.39) KDM4EATML3MBTL1RXRARXRB
SCHEMBL19738282 0.95 L3MBTL1 (0.42) KDM4EATML3MBTL1RXRARXRB
SCHEMBL19533763 0.95 L3MBTL1 (0.44) KDM4EATML3MBTL1RXRARXRB
SCHEMBL13968691 0.95 L3MBTL1 (0.44) KDM4EATML3MBTL1RXRARXRB
SCHEMBL19533760 0.95 L3MBTL1 (0.44) KDM4EATML3MBTL1RXRARXRB
SCHEMBL13968692 0.95 L3MBTL1 (0.44) KDM4EATML3MBTL1RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9761809-B2 Compound and organic light-emitting device comprising same SAMSUNG DISPLAY CO., LTD. (KR) 2017-09-12 — — US disclosed
US-9761809-B2 Compound and organic light-emitting device comprising same SAMSUNG DISPLAY CO., LTD. (KR) 2017-09-12 — — US disclosed
US-20160126465-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-05-05 — — US disclosed
US-20160126465-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160126465-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, LEF1 KDM4E 3284/4885ATM 1946/4885L3MBTL1 216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback